Skip to main content
Close
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Board & Staff
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes are awarded to foreign-born individuals for extraordinary achievement in the arts and sciences.

    • About the Prizes

      Learn more about the Vilcek Foundation Prizes and the prizewinners.

    • Vilcek Prizes

      Awarded to immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Awarded to young immigrant professionals who have demonstrated outstanding achievement early in their careers.

    • Vilcek Prize for Excellence

      Awarded to immigrants who have had a significant impact on American society, or to individuals who are dedicated champions of immigrant causes.

    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
Sign Up Search
Home > Prizes > Prize Recipients > Alexander Rudensky

Alexander Rudensky

2018 Vilcek Prize in Biomedical Science

Location

New York, NY

Title

Director, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center

Area(s) of Research

Immunology; autoimmune disorders; inflammatory disease; cancer

Education

Gabrichevsky Institute for Microbiology and Epidemiology (PhD)

Country of Birth

Russia

Links to learn more about Alexander Rudensky's work
  • mskcc.org

Tags
biochemistry biomedical science cell function immunology Memorial Sloan Kettering Cancer Center molecular biology russia t cells
Share this page
Twitter Facebook LinkedIn

From humble beginnings in the former Soviet Union, Alexander Rudensky counts among the world’s foremost immunologists — for his discoveries on the molecular architecture of regulatory T cells, which play a key role in autoimmune disorders, inflammatory disease, and cancer.

Rudensky was born in Moscow in the late 1950s, and was drawn to science in part, he says, because it was “less influenced by propaganda and politics than other fields.”

A photo of Alexander Rudensky and a student

At Moscow’s Second Medical School, he pursued biochemistry and studied the interplay between the immune system’s main actors: T cells and B cells. Rudensky did immunological postdoctoral work at Yale and accepted a professorship at the University of Washington, where his focus turned to the molecular underpinnings of T cell development.

Rudensky became particularly interested in regulatory T cells, or Tregs, thought to play a role in suppressing unwanted immune responses. The molecular identity and role of Tregs had puzzled researchers for decades, but Rudensky and his team helped solve it by discovering that the gene switch FOXP3 controls their formation.

A photo of Alexander Rudensky inside of his lab at Memorial Sloan Kettering

Much of Rudensky’s career unfolded at Memorial Sloan-Kettering in New York City. Notably, he found that placental mammals form cohort of “peripheral” Tregs, and that during pregnancy, these Tregs prevent the maternal immune system from attacking the fetus, effectively linking peripheral Treg deficiency to miscarriages. Rudensky also discovered that fatty acids in the gut boost the formation of peripheral Tregs, which in turn help ward off inflammatory gut disorders, and that Tregs secrete a signaling molecule that mediates tissue repair and maintenance, establishing a central role for them in inflammation and allergies.

More recently, Rudensky and his colleagues have explored how Tregs influence cancer progression. Clinical trials involving Tregs in transplantation and autoimmune diseases are underway, and the coming years are poised to bring promising leads for cancer treatment.

 

Awards and Accomplishments

  • Crafoord Prize in Polyarthritis (2017)
  • Member of the American Academy of Arts and Sciences (2015)
  • William B. Coley Award (2015)
  • Fellow of the National Academy of Sciences (2012)
Tags
biochemistry biomedical science cell function immunology Memorial Sloan Kettering Cancer Center molecular biology russia t cells

Jury Members

2018 Vilcek Prize in Biomedical Science

Titia de Lange

Leon Hess Professor and Head of the Laboratory of Cell Biology and Genetics, The Rockefeller University

Dan R. Littman

Helen L. and Martin S. Kimmel Professor of Molecular Immunology, New York University School of Medicine

Joan Massagué

Director, Memorial Sloan Kettering Cancer Center

Ruslan Medzhitov

Sterling Professor of Immunobiology, Yale School of Medicine

Huda Y. Zoghbi

Professor of Molecular and Human Genetics, Pediatrics, and Neuroscience, Baylor College of Medicine
Share this page
Twitter Facebook LinkedIn

Related Prize Recipients

Alexander Varshavsky

Alexander Varshavsky receives the Vilcek Prize in Biomedical Science for fundamental insights into the role of regulated protein degradation and the ubiquitin system in controlling protein levels within cells, with implications for an array of diseases, including cancer.
Alexander Varshavsky

Vishva M. Dixit

Vishva M. Dixit receives the Vilcek Prize in Biomedical Science for his groundbreaking discoveries on the mechanism of apoptosis - a biochemical process of programmed cell death.
Portrait of Vishva M. Dixit

Angelika Amon

Angelika Amon (1967-2020) receives the Vilcek Prize in Biomedical Science for groundbreaking research on the molecular signals that regulate cell growth and division, and how errors in these processes contribute to birth defects and cancer.
Portrait of Angelika Amon

You may also be interested in

March 29, 2022

Katalin Karikó: The sacrifices and successes of immigrant scientists

Amid multiple awards for the development of mRNA vaccines, Hungarian biochemist Katalin Karikó insists that her greatest success has been being able to show up every day for a career she is passionate about.
Katalin Karikó standing in the woods in a beige coat with fur trim.
February 22, 2022

Vishva M. Dixit: A scientist who swings for the fences

Vilcek Prizewinner Vishva M. Dixit’s career has been fueled by his passion for discovery, and his ambition to make a lasting impact on medicine.
Vishva Dixit with a big smile and a multicolor button-down.
February 8, 2019

Mutations and Multiplication: Angelika Amon Unravels Cell Division

“We showed how the cell cycle is interconnected,” Angelika says, “and how one cell cycle phase sets up the next one.”
A photo of Angelika Amon

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Board and Staff
    • Press Center
    • Contact
  • Prizes
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
  • Careers
Connect with us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube
  • Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2023   Vilcek Foundation